Does RUXOLITINIB Cause Leukaemia? 321 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 321 reports of Leukaemia have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.5% of all adverse event reports for RUXOLITINIB.
321
Reports of Leukaemia with RUXOLITINIB
0.5%
of all RUXOLITINIB reports
115
Deaths
142
Hospitalizations
How Dangerous Is Leukaemia From RUXOLITINIB?
Of the 321 reports, 115 (35.8%) resulted in death, 142 (44.2%) required hospitalization, and 11 (3.4%) were considered life-threatening.
Is Leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 321 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Leukaemia?
RANITIDINE (1,040)
VENETOCLAX (385)
IMATINIB (242)
ADALIMUMAB (239)
LENALIDOMIDE (219)
NILOTINIB (176)
CLOZAPINE (156)
METHOTREXATE (142)
ETANERCEPT (139)
CYCLOPHOSPHAMIDE (126)
Which RUXOLITINIB Alternatives Have Lower Leukaemia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE